- Home
- XRTX vs HSCS Comparison
XRTX vs HSCS Comparison
Compare XRTX & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- HSCS
- Stock Information
- Founded
- XRTX 2011
- HSCS 2007
- Country
- XRTX Canada
- HSCS United States
- Employees
- XRTX N/A
- HSCS N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- HSCS Medical Specialities
- Sector
- XRTX Health Care
- HSCS Health Care
- Exchange
- XRTX Nasdaq
- HSCS Nasdaq
- Market Cap
- XRTX 4.2M
- HSCS 3.7M
- IPO Year
- XRTX N/A
- HSCS 2022
- Fundamental
- Price
- XRTX $0.92
- HSCS $3.58
- Analyst Decision
- XRTX
- HSCS Strong Buy
- Analyst Count
- XRTX 0
- HSCS 2
- Target Price
- XRTX N/A
- HSCS $13.00
- AVG Volume (30 Days)
- XRTX 34.6K
- HSCS 47.2K
- Earning Date
- XRTX 05-16-2025
- HSCS 07-28-2025
- Dividend Yield
- XRTX N/A
- HSCS N/A
- EPS Growth
- XRTX N/A
- HSCS N/A
- EPS
- XRTX N/A
- HSCS N/A
- Revenue
- XRTX N/A
- HSCS N/A
- Revenue This Year
- XRTX N/A
- HSCS N/A
- Revenue Next Year
- XRTX N/A
- HSCS N/A
- P/E Ratio
- XRTX N/A
- HSCS N/A
- Revenue Growth
- XRTX N/A
- HSCS 261.17
- 52 Week Low
- XRTX $0.80
- HSCS $2.36
- 52 Week High
- XRTX $2.98
- HSCS $5.90
- Technical
- Relative Strength Index (RSI)
- XRTX 43.86
- HSCS 49.06
- Support Level
- XRTX $0.88
- HSCS $3.48
- Resistance Level
- XRTX $0.97
- HSCS $4.29
- Average True Range (ATR)
- XRTX 0.06
- HSCS 0.47
- MACD
- XRTX -0.01
- HSCS -0.04
- Stochastic Oscillator
- XRTX 18.85
- HSCS 22.58
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.